ASCO Direct™ Highlight: 2020 Official Annual Meeting Review
September 26, October 3, October 10, October 17
ICAHO20 is an educational meeting intended to improve the care of cancer patients by educating hematologists, oncologists, oncology pharmacists, oncology nurses and nurse practitioners and others involved in the management of cancer patients about the latest developments in the field. ICAHO20 is an officially licensed ASCO Direct™ Highlight: 2020 Official Annual Meeting Review.
ICAHO20 is the 8th annual hematology oncology conference organized by the Binaytara Foundation in the pacific northwest.
ASCO Direct™ is an officially licensed program of the American Society of Clinical Oncology® (ASCO®) that provides most relevant scientific meeting highlights and perspectives for oncologists and other practitioners.
Please watch the video below if you are having difficulties logging into our Zoom meeting or moving between exhibit rooms and the main meeting room
Please complete the following activity evaluations if you participated in any of ICAHO20: ASCO Direct™ Highlights Sessions
- Oncology Nurse Practitioners
- Oncology Pharmacists
- Oncology Physician Assistants
- Oncology Fellows/Residents
- Oncology Nurses
- Researchers and others involved in the care of cancer patients
At the conclusion of the activity, participants will be able to:
- Discuss new and updated treatment options for patients with hematologic malignancies and solid tumors
- Identify side effects, indications, and contra-indications of therapies used to diagnose and treat cancers
- Explain how to effectively manage side-effects associated with cancer treatment
- Review abstracts presented at ASCO® 2020 and discuss their application in clinical settings
JOINT PROVIDERSHIP STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Utah Medical Association (UMA) through the joint providership of the Ada Canyon Medical Education Consortium and the Binaytara Foundation.
The Ada Canyon Medical Education Consortium is accredited by the Utah Medical Association to provide continuing medical education for physicians. The Ada Canyon Medical Education Consortium designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 10.5 Contact Hours
COMMERCIAL SUPPORT ACKNOWLEDGEMENT
This educational activity has been supported by Independent Medical Education Grant from the following companies:
- Taiho Pharmaceuticals
- Jazz Pharmaceuticals
- Ipsen Pharmaceuticals
- Dova Pharmaceuticals, and
Roland Walter, MD, PhD, MS
Fred Hutchinson Cancer Research Center
David Aboulafia, MD
Virginia Mason Cancer Institute
Shailender Bhatia, MD
Seattle Cancer Care Alliance